Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV04/06/2024 | Diferencia+8.8101 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 2,201.1001GBP | +0.40% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | 10.22 | 10.74 | 1.48 | -1.69 | 0.14 | 7.21 | -2.22 | 2.49 | 1.44 | - |
| 2021 | 0.09 | -5.90 | 1.24 | 1.97 | -2.18 | 6.26 | -1.59 | 6.66 | -1.78 | 1.68 | -2.99 | 1.57 | +4.39% |
| 2022 | -9.64 | -1.76 | 6.66 | -1.27 | -1.71 | 3.82 | 4.16 | 1.30 | -0.67 | 3.78 | 2.55 | -4.40 | +1.72% |
| 2023 | -0.19 | -2.26 | -0.73 | 1.15 | -1.18 | -2.43 | -0.31 | -0.51 | -1.63 | -5.81 | 4.68 | 5.01 | -4.59% |
| 2024 | 1.47 | 4.84 | 1.63 | -2.53 | 0.79 | 0.63 | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 10.88% | 10.84% | 11.41% | 14.42% | -% |
| Índice de Sharpe | 1.22 | 1.73 | -0.06 | 0.07 | - |
| El mes mejor | +5.01% | +5.01% | +5.01% | +6.66% | +10.74% |
| El mes peor | -2.53% | -2.53% | -5.81% | -9.64% | -9.64% |
| Pérdida máxima | -4.95% | -4.95% | -12.94% | -18.83% | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en GBP
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,367.2800 | +6.52% | +4.60% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,529.7300 | +6.66% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.7500 | +3.02% | -6.21% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,201.1001 | +3.10% | +14.90% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,588.4700 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 241.6300 | +3.56% | +12.59% | |
| Candriam Equities L Oncology Imp... | paying dividend | 232.8300 | +5.19% | +0.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 188.6100 | +6.09% | +3.30% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,379.0000 | +1.22% | +0.36% | |
| Candriam Equities L Oncology Imp... | reinvestment | 155.7100 | +2.98% | +14.51% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,082.6499 | +4.00% | -3.52% | |
| Candriam Equities L Oncology Imp... | reinvestment | 256.1200 | +4.44% | +15.47% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.2100 | +2.61% | -7.31% | |
| Candriam Equities L Oncology Imp... | reinvestment | 282.8100 | +6.08% | +3.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.2800 | +3.89% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,815.7800 | +3.43% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,843.2800 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 155.3200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.5100 | +5.19% | +0.71% |
Performance
| Año hasta la fecha | +6.88% | ||
|---|---|---|---|
| 6 Meses | +10.66% | ||
| Promedio móvil | +3.10% | ||
| 3 Años | +14.90% | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | +46.74% | ||
| Año | |||
| 2023 | -4.59% | ||
| 2022 | +1.72% | ||
| 2021 | +4.39% | ||
